Clinical trials have shown promising results for semaglutide as a weight loss treatment. In a study of over 2,000 overweight or obese adults, those who took semaglutide for 68 weeks lost an average of 15% of their body weight, compared to 2.4% in the placebo group. In addition, semaglutide has been shown to improve other health markers, such as blood pressure and cholesterol levels. This has led to the approval of semaglutide for the treatment of obesity in the United States.
It is also important to note that semaglutide should not be used as a standalone treatment for weight loss. It should be used in conjunction with a healthy diet and exercise regimen to achieve the best results.